(Press-News.org) A new study has calculated the average cost per case of TB in the EU. The findings suggest the economic burden of TB far outweighs the costs of investing in more effective vaccines.
The research, published online today (16 August 2013), in the European Respiratory Journal, is the first study to estimate the costs of the disease in recent years.
Researchers used a systematic review of literature and institutional websites for the 27 EU member states to summarise economic data on the treatment cost of TB cases in 2011.
The researchers separated the countries into two groups based on their gross domestic product (GDP) per person. The findings revealed the costs as follows:
For the old EU-15 countries, plus Cyprus, Malta and Slovenia, on average the costs per case were:
€10,282 for drug-susceptible TB
€57,213 for multidrug-resistant (MDR) TB
€170,744 for extensively drug resistant (XDR) TB
For the remaining new EU states, the costs amounted to:
€3,427 for drug-susceptible TB
€24,166 for MDR-TB/XDR-TB
The authors calculated that of the total treatment cost of drug-susceptible, MDR-TB and XDR-TB cases in 2011 was €536,890,315.
The researchers also calculated the disability-adjusted life years (DALYs) caused by TB. DALYs are a measure of disease burden, looking at the number of years lost due to ill-health, disability or early death. The total number of years lost amounted to 103,104 in 2011. When stated in monetary terms, this amounted to €5,361,408,000.
The findings come ahead of the launch of the European Lung White Book, a comprehensive publication that will provide burden and cost data for a range of respiratory diseases and risk factors. The launch will take place at this year's European Respiratory Society's Annual Congress in Barcelona next month (7 September 2013).
Lead author, Roland Diel, professor for Health Economics at the University Hospital Schleswig–Holstein in Kiel, Germany, , said: "This is the first time that a comprehensive cost-per-case has been estimated for TB. Without better vaccines, it is unlikely that TB will ever be eliminated. An investment of about 560 million is considered necessary to develop a new, effective vaccine in the EU.
"The findings of our study suggest that this investment is essential as the costs of the current economic burden far outweigh the cost of investing in new treatments."
Francesco Blasi, President of the European Respiratory Society, said: "The figures in this study have shown that the burden of TB on both the economy and on society in Europe is huge, particularly with the increasing problem of drug-resistant strains. The widely used BCG vaccine was introduced in 1921; it is out of date and has unpredictable success in preventing TB. It is time to invest more of our resources in preventing this debilitating condition.
"It is critical that healthcare professionals and policymakers take note of this new data to understand the impact and burden of diseases. That is why we have produced the White Book, which includes the latest data on over 20 different respiratory diseases in Europe."
###
The European Lung White Book will be launched at the European Respiratory Society annual Congress in Barcelona on 8 September 2013. The White Book will be available online and in print from September 2013: http://whitebook.ersnet.org
New study puts a price on drug-resistant TB cases in EU
2013-08-16
ELSE PRESS RELEASES FROM THIS DATE:
Study shows both a Mediterranean diet and diets low in available carbohydrates protect against type 2 diabetes
2013-08-16
New research shows that a Mediterranean-style diet and diets low in available carbohydrates can offer protection against type 2 diabetes. The study is published in Diabetologia, the journal of the European Association for the Study of Diabetes (EASD), and is by Dr Carlo La Vecchia, Mario Negri Institute of Pharmacological Research, Milan, Italy, and colleagues.
The authors studied patients from Greece who are part of the ongoing European Prospective Investigation into Cancer and nutrition (EPIC), led by Dr. Antonia Trichopoulou, from the University of Athens. From a ...
More potent anti-clotting drugs with angiography may benefit patients with acute chest pain
2013-08-16
Boston, MA – Current methods to treat acute coronary syndrome conditions, such as heart attack, include artery-clearing procedures (e.g., percutaneous coronary intervention or coronary artery bypass grafting) with medications, or medications alone for those that do not undergo procedures.
In a new report from the TRILOGY ACS trial from Brigham and Women's Hospital (BWH) and Duke Clinical Research Institute (DCRI), in patients without artery-clearing procedures, those who had an angiography (a type of x-ray to view the inside of blood vessels) followed by prasugrel (Effient) ...
Slow earthquakes may foretell larger events
2013-08-16
Monitoring slow earthquakes may provide a basis for reliable prediction in areas where slow quakes trigger normal earthquakes, according to Penn State geoscientists.
"We currently don't have any way to remotely monitor when land faults are about to move," said Chris Marone, professor of geophysics. "This has the potential to change the game for earthquake monitoring and prediction, because if it is right and you can make the right predictions, it could be big."
Marone and Bryan Kaproth-Gerecht, recent Ph.D. graduate, looked at the mechanisms behind slow earthquakes ...
A new approach assembles big structures from small interlocking pieces
2013-08-16
CAMBRIDGE, Mass-- MIT researchers have developed a lightweight structure whose tiny blocks can be snapped together much like the bricks of a child's construction toy. The new material, the researchers say, could revolutionize the assembly of airplanes, spacecraft, and even larger structures, such as dikes and levees.
The new approach to construction is described in a paper appearing this week in the journal Science, co-authored by postdoc Kenneth Cheung and Neil Gershenfeld, director of MIT's Center for Bits and Atoms.
Gershenfeld likens the structure — which is made ...
Voyager 1 has left the solar system, says new study
2013-08-16
COLLEGE PARK, Md. – Voyager 1 appears to have at long last left our solar system and entered interstellar space, says a University of Maryland-led team of researchers.
Carrying Earthly greetings on a gold plated phonograph record and still-operational scientific instruments – including the Low Energy Charged Particle detector designed, built and overseen, in part, by UMD's Space Physics Group – NASA's Voyager 1 has traveled farther from Earth than any other human-made object. And now, these researchers say, it has begun the first exploration of our galaxy beyond the ...
Knockout mouse grows larger, but weaker, muscles
2013-08-16
SAN ANTONIO (Aug. 15, 2013) — Although muscle cells did not reduce in size or number in mice lacking a protective antioxidant protein, they were weaker than normal muscle cells, researchers from the Barshop Institute for Longevity and Aging Studies at The University of Texas Health Science Center San Antonio found.
The scientists, who are faculty in the university's School of Medicine, are studying how oxidative stress in cells impacts sarcopenia — a loss of muscle mass and strength that occurs in all humans as they age.
Protein knocked out selectively
The antioxidant ...
Experiences of racism linked to adult-onset asthma in African-American women
2013-08-16
(Boston) – According to a new study from the Slone Epidemiology Center (SEC) at Boston University, African-American women who reported more frequent experiences of racism had a greater likelihood of adult-onset asthma compared to women who reported less frequent experiences.
The study, which currently appears on-line in the journal Chest, was led by Patricia Coogan, DSc, senior epidemiologist at SEC and research professor of epidemiology at Boston University School of Public Health.
This study followed 38,142 African-American women, all of whom are participants in ...
Sugar helps scientists find and assess prostate tumors
2013-08-16
A natural form of sugar could offer a new, noninvasive way to precisely image tumors and potentially see whether cancer medication is effective, by means of a new imaging technology developed at UC San Francisco in collaboration with GE Healthcare.
The technology uses a compound called pyruvate, which is created when glucose breaks down in the body and which normally supplies energy to cells. In cancer, however, pyruvate is more frequently converted to a different compound, known as lactate. Previous animal studies showed that scientists could track the levels of pyruvate ...
Sympathetic neurons 'cross talk' with pancreas cells during early development
2013-08-16
The human body is a complicated system of blood vessels, nerves, organs, tissue and cells each with a specific job to do. When all are working together, it's a symphony of form and function as each instrument plays its intended roles.
Biologist Rejji Kuruvilla and her fellow researchers uncovered what happens when one instrument is not playing its part.
Kuruvilla along with graduate students Philip Borden and Jessica Houtz, both from the Biology Department at Johns Hopkins University's Krieger School of Arts and Sciences, and Dr. Steven Leach from the McKusick-Nathans ...
Answering crucial questions about anthrax exposure
2013-08-16
(SALT LAKE CITY)—If terrorists targeted the United States with an anthrax attack, health care providers and policy makers would need key information – such as knowing the likelihood of an individual becoming infected, how many cases to expect and in what pattern, and how long to give antibiotics – to protect people from the deadly bacteria.
Those questions gained urgency when anthrax-laced letters killed five people and infected 17 others in the wake of the terror attacks of September 2001. Now, using information from prior animal studies and data from a deadly anthrax ...